AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home mLife Article
PDF (3.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Research | Open Access

SARS‐CoV‐2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway

Lihong Liu1,# , Jie Du2,#, Jiacheng Huang1, Sidi Yang1 , Qiaoqiao Xiao3, Liu Cao2, Hong Peng2, Birong Zheng1, Chunmei Li2 , Deyin Guo1,2( )
Guangzhou National Laboratory, Guangzhou, China
Centre for Infection and Immunity Studies (CIIS), School of Medicine, Shenzhen Campus of Sun Yat‐sen University, Shenzhen, China
Guizhou University of Traditional Chinese Medicine, Guiyang, China

#Lihong Liu and Jie Du contributed equally to this study.

Show Author Information

Abstract

The innate immune system functions as the frontline barrier against invading pathogens, such as severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Nevertheless, the virus has developed various strategies to effectively regulate host immune responses, particularly through the inhibition of interferon signaling. In this study, we identify the SARS‐CoV‐2 accessory protein ORF6 as a key inhibitor of interferon gamma (IFNγ) signaling through downregulation of the interferon‐induced 35‐kDa protein (IFP35). IFP35, an interferon‐stimulated gene (ISG) critical for interferon ‐mediated antiviral response, is significantly upregulated during SARS‐CoV‐2 infection. Silencing IFP35 via RNA interference enhances viral replication, indicating its antiviral role. Furthermore, we demonstrate that ORF6 associates with IFP35 and accelerates its ubiquitin–proteasome degradation, thereby impairing IFP35's ability to activate IFNγ signaling. These data reveal novel mechanisms used by SARS‐CoV‐2 to circumvent host immunity, specifically by impairing IFNγ signaling.

References

【1】
【1】
 
 
mLife
Pages 597-610

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Liu L, Du J, Huang J, et al. SARS‐CoV‐2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway. mLife, 2026, 5(5): 597-610. https://doi.org/10.1002/mlf2.70112

6

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 09 December 2025
Accepted: 08 July 2026
Published: 26 October 2026
© 2026 The Author(s). mLife published by John Wiley & Sons Australia, Ltd on behalf of Institute of Microbiology, Chinese Academy of Sciences.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.